Healthy
Conditions
Keywords
Gut microbial, response, to protein-based, diet, challenges, population
Brief summary
Gut microbiota are involved in the regulation of mammalian metabolic pathways through host-microbiota metabolic, signaling, and immune-inflammatory interactions that physiologically connect the gut, liver, brain, and other organs. Correlation of these metabotypes with gut microbial profiles facilitates deciphering inherent host-microbe relationships. Microbiome sequencing have generated novel insights into the role of gut microbial composition in health and disease, but are limited in addressing the microbial contribution to host metabolism and the gut microbial dysbiosis in disease. This is an exploratory trial, aiming to examine how gut microbial conditions determine response to dietary challenge by measuring urine, plasma and stool metabolites resulting from metabolism of protein, polyamines and bile acids in combination with stool bacterial composition. The focus of this trial is to evaluate impact of protein based food challenges, based on cross-over design of two diet challenges of animal and vegan protein sources.
Interventions
OTHERAnimal-based protein diet
OTHERVegan-based protein diet
Sponsors
Société des Produits Nestlé (SPN)
Study design
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
Yes
Inclusion criteria
* Caucasian * Regular bowl movement (at least once every 1-2 days) * Between 18 and 55 years old * BMI between 18.5 and 27 kg/m2 (inclusive) * Willing and able to sign written informed consent prior to trial entry
Exclusion criteria
* Clinically relevant digestive, renal or metabolic disease, as determined by the medical (screening) visit and a standard blood chemistry analysis (glucose, total cholesterol, LDL, HDL, triglycerides, Aspartate aminotransferase (ASAT), Alanine aminotransferase (ALAT), gamma glutamyl transferase (Gamma-GT), C reactive protein (CRP), creatinine) * Undergoing regular medical treatment, pain-killers accepted, based on the medical questionnaire * Special diets: vegetarian, high protein or weight loss program (anamnesis) * Pregnancy (anamnesis) * Food allergy * Participation in a cholesterol management program with functional foods like food supplement enriched in omega-3 fatty acids, dairy products enriched with phytosterols (margarines, yoghurts), evaluated during the medical visit * Practicing more than 5 moderated physical activity per week * Smoker (anamnesis) * Have a high alcohol consumption (more than 2 drinks/day) (anamnesis) * Consumption of illicit drugs, (anamnesis) * Having given blood within the last month, or willing to make a blood donation until one month following the end of the study * Subject who cannot be expected to comply with the study procedures, including consuming the test products. * Currently participating or having participated in another clinical trial during the last month prior to the beginning of this study.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Intra-individual plasma, stools, and urine omics to acute controlled feeding | 3-Day baseline, 3-Day diet challenge 1, 1-Day baseline after challenge 1 washout, 3-Day diet challenge 2, 1-Day baseline after challenge 2 washout | Metabonomics on fasting blood, urine, and stools and microbiota composition by 1. defining individual baseline (3-Day baseline before start of diet challenges); 2. Examining effect of the dietary challenges (3-Day diet challenge vs. Baseline); 3. Examining global dietary effect (baseline after challenge 2 vs. baseline after challenge 1) and stability of dietary effect (3rd day of each diet challenge vs. baseline after the challenge) |
| Intra-individual plasma biochemistry response to acute controlled feeding | Day 1 and 3 of diet challenge 1, 1-Day baseline after challenge 1 washout, Day 1 and 3 of diet challenge 2, 1-Day baseline after challenge 2 washout | To evaluate effect of the dietary challenges (Day 3 vs Day1 of each diet challenge), the global dietary effect (baseline after challenge 2 vs. the baseline after challenge 1, Day 1 of diet challenge 1), stability of the dietary effect (3rd day of each diet challenge vs. baseline after the challenge) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Subject's omics adaptation phase to a controlled diet Subject's omics adaptation phase to a controlled diet | 3-Day diet challenge 1 and 2 | Through analysis of metabonomics on fasting blood, daytime blood, urine, and stools and microbiota composition |
| Comparison of intra-individual daytime plasma response amongst diets and free living restricted diets | 3-Day baseline before start of diet challenges, 3-Day diet challenge 1, 1-Day baseline after challenge 1 washout, 3-Day diet challenge 2, 1-Day baseline after challenge 2 washout | Through analysis of metabonomics on fasting blood, daytime blood, urine, and stools and microbiota composition |
| Pairing of gut microbial metabolite to gut microbial composition to generate concept on gut functional system to be followed-up in future studies | 3-Day baseline before start of diet challenges, 3-Day diet challenge 1, 1-Day baseline after challenge 1 washout, 3-Day diet challenge 2, 1-Day baseline after challenge 2 washout | Through analysis of metabonomics on fasting blood, daytime blood, urine, and stools and microbiota composition |
| Pairing dietary intake and preferences with subjects response in Omics endpoints | 3-Day baseline before start of diet challenges, 3-Day diet challenge 1, 1-Day baseline after challenge 1 washout, 3-Day diet challenge 2, 1-Day baseline after challenge 2 washout | Through analysis of metabonomics on fasting blood, daytime blood, urine, and stools and microbiota composition and 3- Days dietary recall during diet challenges and food frequency questionnaire at baseline before start of diet challenges |
Countries
Switzerland
Outcome results
None listed